Peter Nalos is a Cardiology physician affiliated with Cedars-Sinai Medical Center. OpenAlex indexes 17 publications with 367 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2901 Sillect Ave
Suite 100
Bakersfield, CA 933086370
Telephone
661-323-8384Registry record last updated 29 Oct 2009.
Industry payments
24 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year202525 payments
- HEARTFLOW, INC.Program year20252 payments
- Novartis Pharmaceuticals CorporationProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
83.9%Beta blocker26%Metoprolol Succinate30%Sotalol26%Metoprolol Tartrate14%Nebivolol Hcl9%Carvedilol8%Atenolol6%Propranolol Hcl6%Sotalol Af2%Part D≥136 patientsAntiarrhythmic12%Flecainide Acetate60%Amiodarone Hcl39%Mexiletine Hcl2%Part D<11 patients+ 19 more classes in this area
Blood & clotting
11.3%Factor Xa inhibitor7.7%Eliquis78%Xarelto22%Part D≥88 patientsP2Y12 inhibitor2.3%Clopidogrel100%Part D≥44 patients+ 1 more class in this area
Metabolism & gastrointestinal
3.1%Potassium supplement2%Potassium Chloride100%Part D≥45 patientsSGLT2 inhibitor0.5%Farxiga54%Jardiance46%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- High dose oral amiodarone loading: Electrophysiologic effects and clinical tolerance
Journal of the American College of Cardiology
1992 - Intravenous amiodarone for short-term treatment of refractory ventricular tachycardia or fibrillation
American Heart Journal
1991 - Benefits of Intracardiac Electrograms and Programmable Sensing Polarity in Preventing Pacemaker Inhibition Due to Spurious Screw‐In Lead Signals
Pacing and Clinical Electrophysiology
1990
Similar KOLs
Other experts from the same institution or the same specialty.
Raj Makkar, MD
Cedars-Sinai Medical Center
Eduardo Marban, MD
Cedars-Sinai Medical Center
Stephen Freedland, MD
Cedars-Sinai Medical Center
Cristina Ferrone, MD
Cedars-Sinai Medical Center
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”